Chromosomal aberrations of Don lung cells of Chinese hamster after exposure to vinblastine in vitro. 1979

M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
May 1969, Die Naturwissenschaften,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
August 1992, Cancer genetics and cytogenetics,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
October 2017, Mutation research. Genetic toxicology and environmental mutagenesis,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
November 1980, Mutation research,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
April 1974, Mutation research,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
July 1979, Mutation research,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
August 1995, Mutation research,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
October 1967, Journal of the National Cancer Institute,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
November 1992, Mutation research,
M Segawa, and S Nadamitsu, and K Kondo, and I Yoshizaki
May 2001, Mutation research,
Copied contents to your clipboard!